scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1046/J.1440-1681.1999.03494.X |
P698 | PubMed publication ID | 11473527 |
P50 | author | Alastair Stewart | Q63373438 |
P2093 | author name string | D J Fernandes | |
K F Xu | |||
P433 | issue | 8 | |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 619-629 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Clinical and Experimental Pharmacology and Physiology | Q5133807 |
P1476 | title | Anti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling | |
P478 | volume | 28 |
Q46861382 | Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? |
Q35093296 | MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway |
Q64072479 | Modeling the pasture-associated severe equine asthma bronchoalveolar lavage fluid proteome identifies molecular events mediating neutrophilic airway inflammation |
Q34754688 | New asthma targets: recent clinical and preclinical advances |
Q35127841 | Recurrent airway obstruction--heaves |
Q36474311 | The role of oxidative stress in an equine model of human asthma |
Q36312384 | What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease? |